Cadavid Diego 4
4 · X4 Pharmaceuticals, Inc · Filed Jan 6, 2021
Insider Transaction Report
Form 4
Cadavid Diego
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-12-31$6.43/sh+121,500$781,245→ 121,500 totalExercise: $6.43Exp: 2030-12-31→ Common Stock (121,500 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on December 31, 2021, with the remainder vesting in equal installments of 2.0833% of the shares subject to the option each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date.